On April 16, ADVI Health’s senior director, federal agency engagement, and co-lead of ADVI’s Inflation Reduction Act (IRA) Center of Excellence, John Coster, was featured in STAT discussing Trump’s recent executive order to lower drug pricing.

In the article, “Trump’s plans to lower drug prices have echoes of past efforts,” John shares that the order calls for speeding reviews of generics and biosimilars, and also expands on how tariffs will affect the making of these drugs.

Read more in STAT.